Ask an Expert

Question of the Day

Eric J. Nestler, M.D., Ph.D. - Brain & behavior research expert on depression
September 11, 2013

Several rapidly acting antidepressants are currently in clinical trial, such as ketamine (see 2011 Highlights, Dr. Zarate, on p.2). These rapidly acting agents have novel mechanisms compared to currently available antidepressants and could offer significant improvement to patients who do not fully respond to today's medications. In addition, efforts continue to identify even more antidepressant medications with novel mechanisms of action.

 

Eric J. Nestler, M.D., Ph.D.
Scientific Council Member
Nash Family Professor of Neuroscience
Chair, Department of Neuroscience
Director, Friedman Brain Institute
Mount Sinai School of Medicine

Q What type of blood pressure medication interferes with Antidepressant LImbitrol?
A More >
Karl Deisseroth, M.D., Ph.D. - Brain and behavior research expert on schizophrenia
Q Can you envision ways in which the optogenetics technology that you invented might eventually improve the design or use of psychiatric medications?
A The major challenge we face in psychiatry is understanding. Psychiatric... More >